Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 169Head and Neck Neoplasms 151Carcinoma, Squamous Cell 33Neoplasm Metastasis 18Laryngeal Neoplasms 17Colorectal Neoplasms 17Tongue Neoplasms 16Neoplasms 16Mouth Neoplasms 16Recurrence 14Oropharyngeal Neoplasms 14Carcinoma, Non-Small-Cell Lung 14Salivary Gland Neoplasms 12Hypopharyngeal Neoplasms 11Carcinoma 11Laryngeal Diseases 10Breast Neoplasms 10Nasopharyngeal Carcinoma 9Pancreatic Neoplasms 6Neoplasms, Squamous Cell 6Sarcoma 5Pharyngeal Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Colonic Neoplasms 5Carcinoma, Renal Cell 5Stomach Neoplasms 4Rectal Neoplasms 4Ovarian Neoplasms 4Melanoma 4Lymphoid Interstitial Pneumonia 4

Interventions

pembrolizumab 1Radiotherapy 1Oncolytic Virotherapy 1Hydroxyurea 1Fluorouracil 1Cetuximab 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nose Neoplasms × Cetuximab × Head & Neck × Clear all
NCT00462735 2018-03-13

Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer

Icahn School of Medicine at Mount Sinai

Phase 2 Completed
33 enrolled 15 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Nose Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡